The CXCL12 chemokine mediated pro-angiogenic and prometastatic effects through receptors CXCR4 and CXCR7, while the neutralization of this chemokine reduced the angiogenic potential of the tumor [49]. This evidence concerns the gene CXCR4 and neoplasm.